Pharmacists: Malaysia's frontline warriors against tobacco, vaping
Its president, Amrahi Buang, said pharmacists across the country continue to play a critical role in helping Malaysians quit tobacco, particularly through the Health Ministry's mQuit programme.
'Since the inception of the mQuit programme, MPS has collaborated closely with the ministry to train pharmacists in smoking cessation pharmacotherapy.
'Pharmacists are professionally equipped and stationed across public hospitals, health clinics and private community pharmacies where they deliver person-centred cessation counselling, nicotine replacement therapy interventions and behavioural support.
'Thousands of Malaysians ready to quit smoking have benefited from the mQuit programme since its inception,' he said in a statement on Saturday (May 31).
Amrahi also highlighted Malaysia's strong representation at the international level, with Health Minister Datuk Seri Dr Dzulkefly Ahmad, the ministry's disease control division deputy director Dr Noraryana Hassan and Malaysian Council for Tobacco Control (MCTC) chairman Assoc Prof Dr Murallitharan Munisamy being named recipients of the World Health Organisation's World No Tobacco Day 2025 Award.
He added that their recognition aligns with Malaysia's multi-stakeholder approach to combating tobacco use and vaping-related harms.
Amrahi said MPS has long championed bold legislative reforms, including support for the Generational End Game provision to protect those born after 2007 from tobacco and vape addiction.
He said MPS has reaffirmed its commitment to tobacco control efforts and would continue to engage across sectors and platforms to strengthen tobacco control efforts, both nationally and internationally.
These include participation in bodies such as the MCTC, the mQuit Services Committee, the Poisons Board, the Drug Control Authority and the Pharmacy Board of Malaysia.
On the ground, the society supports school campaigns, inter-professional partnerships and public awareness initiatives to build a healthier, tobacco-free generation.
The society also continues to advocate for the restoration of regulatory safeguards and nationwide enforcement against the sale of illegal vapes and unlicensed outlets.
'We must not waver in our stance that health must come before profits, and that the nation's legislative framework must reflect this principle,' Amrahi said.
'As we mark World No Tobacco Day 2025, we renew our commitment to advocate without fear or favour, equip pharmacists with tools for intervention and stand united with all public health champions, across professions and politics, for the health of our nation.
'In the words of the World Health Organisation, 'We need food, not tobacco.' MPS responds: We need health, not harm. We need action, not delay,' said Amrahi.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Free Malaysia Today
38 minutes ago
- Free Malaysia Today
Unpacking the truth about palm oil consumption
Research has shown that, when used in moderation as part of a balanced diet, palm oil does not pose health risks. (Freepik pic) KUALA LUMPUR : A recent national survey commissioned by Pertubuhan Transformasi Dayak found that 37% of Malaysians believe palm oil causes high cholesterol. This finding highlights a widespread misconception that should be clarified through better public health communication and science-based education. While palm oil is often misunderstood and wrongly assumed to contribute to high cholesterol and heart disease, it is a plant-based oil that contains no dietary cholesterol. The assumption that it is harmful likely stems from outdated or oversimplified views on dietary fats. A comprehensive review published in the National Library of Medicine in 2023 analysed 31 studies involving nearly 2,400 participants. The findings showed that palm oil does not increase the risk of cardiovascular disease when compared to other commonly used vegetable oils such as soybean, olive, or sunflower. The study also found no significant negative effects on cholesterol levels in healthy individuals. Palm oil has a balanced fatty acid profile, with approximately 50% saturated fat, 40% monounsaturated (heart-healthy) fats and 10% polyunsaturated fats. This composition can help reduce LDL (bad) cholesterol. Moreover, palm oil is naturally trans-fat free and does not undergo the industrial hydrogenation process that may create trans fats in other oils. Trans fats are typically produced by partially hydrogenating liquid vegetable oils to extend shelf life and change texture. This process alters the fat's structure and introduces well-documented health risks. Palm oil, by contrast, is naturally semi-solid at room temperature and stable during high-heat cooking, eliminating the need for hydrogenation. Instead of placing blame on a single ingredient, Malaysians are urged to look at their overall lifestyles, including diets and activity levels. (Envato Elements pic) It is also important to recognise that high cholesterol is usually the result of a combination of factors. These include poor diets, lack of physical activity, smoking, stress, inadequate sleep, or genetics. Singling out palm oil oversimplifies a complex issue and distracts from the more significant contributors to cardiovascular risk. Palm oil is widely used in Malaysian households. It is locally produced, widely used, and economically important. It is also affordable and accessible to the majority of households. When used in moderation as part of a balanced diet, palm oil does not pose any health risks. As we continue to encourage healthy lifestyles, we must ensure our public messaging reflects current scientific understanding. Outdated assumptions should not guide how we view food and health; instead, a more informed, balanced conversation around nutrition should be fostered. Malaysians are also urged to shift the focus from blame to balance. Instead singling out an ingredient, look at overall lifestyles, including diets, activity levels, stress, and habits. It is equally important for policymakers, educators, and healthcare professionals to come together and strengthen public understanding. When we ground our decisions in science instead of speculation, we make real progress in improving heart health. This article was written by Dr Malar Santhi Santherasegapan, a medical doctor and social media health influencer.
The Star
2 hours ago
- The Star
Following S'pore on vapes
Firm stance: Vaping has been banned in Singapore since 2018 and under current laws, possession, using or buying vapes carries a maximum fine of S$2,000 (RM6,574). PETALING JAYA: Malaysia should look to Singapore's model of treating vaping as a drug offence and consider imposing tougher penalties to curb its rising use, particularly among teenagers, say health experts and activists. Consumers Association of Penang (CAP) senior education officer NV Subbarow said the country should look at the issue similar to how Singapore is handling it. 'In our country, most vapes contain addictive and dangerous ingredients, including the dangerous etomidate. 'We should not treat these problems as very light,' he said when contacted yesterday. On Aug 17, Singapore said it will toughen its stance on vaping, treating it as a drug issue with harsher penalties, including jail for sellers of vapes with harmful substances. Vaping has been banned in Singapore since 2018 and under current laws, possession, using or buying vapes carries a maximum fine of S$2,000 (RM6,574). Etomidate, currently under Singapore's Poisons Act, will soon be listed as a Class C drug, subjecting vape users to rehabilitation programmes, similar to drug abusers. Doctors typically inject etomidate to induce sedation, but misusing it can cause hallucinations and permanent organ failure. On July 30, Health Minister Datuk Seri Dr Dzulkefly Ahmad said a thorough study will be conducted before any decision is made to list etomidate as a dangerous drug under the law. The Health Minister said that the ministry took heed of the recent proposal to list the substance under the Dangerous Drugs Act 1952, but would not make a hasty decision without proper evidence. Subbarow revealed that according to a survey conducted by CAP, it shows that the number of cigarette smokers is decreasing and use of vape and e-cigarettes among students and youths is increasing day by day. 'This includes young females who are taking up vaping. They do this without any fear. They reply it's their choice and equality rights,' said Subbarow. He added that it's time for lawmakers to voice out the dangers of drugs in vape liquids and take stern action on it. Ikram Health Malaysia president Dr Mohd Afiq Mohd Nor also agreed, saying that Singapore has a strong and consistent stance on this issue. He suggested that, while waiting for the government to make a decision on banning the substance, the authorities should fully enforce the Control of Smoking Products for Public Health Act 2024 (Act 852). 'Consistency is key before the problem gets worse,' he said. Malaysian Pharmacists Society (MPS) president Prof Amrahi Buang said his organisation has raised this concern since 2015. 'MPS has made a stand on zero tolerance on vape in our National Pharmacists Convention 2025 held recently on July 25. 'We need to protect the rakyat and the nation from this menace. The threats are really harmful,' he said. Public health medicine specialist Prof Dr Sharifa Ezat Wan Puteh pointed out that there are a lot of countries that banned vape but do not deem vape users as drug users. These include Thailand, Hong Kong, Brunei and India, but with different standardisation. Samsul Kamal Ariffin, president of the Malaysian Vape Entities Organisation, said any move to follow Singapore must be done based on scientific facts and not perception. Senior lawyer Mohamed Haniff Khatri Abdulla said there are a lot of steps that needed to be done if Malaysia wants to follow the same steps as Singapore on this issue. 'There must be various studies to be done first, to ascertain all type of vapes and whether the substances used by vape contained drug substances or otherwise,' he said. The relevant authorities must also carry out various tests to determine the legal substances that can or cannot be used as well as controlled, he said. Health Parliament Special Select Committee chairman Suhaizan Kayat said one of the possible ways was to introduce certain amendments to the Control of Smoking Products for Public Health Act 2024 (Act 852) in order to ban vaping.
New Straits Times
15 hours ago
- New Straits Times
Medical insurance made fairer: Standard premiums for M40 under MHIT
KUALA LUMPUR: Premiums for the basic medical and health insurance/takaful product (MHIT) are set to be standardised, with a focus on affordability for the M40 income group. This is in line with government efforts to broaden access to private hospital care, according to Bank Negara Malaysia. The product, being developed jointly by Bank Negara and the Health Ministry, is expected to be launched in the second half of 2026. It will be offered as a standard plan providing essential coverage at a sustainable cost. The information was shared during the RESET media strategy workshop organised by Bank Negara and the ministry at Sasana Kijang here today. Bank Negara said the initiative is expected to act as a catalyst for restructuring the private health insurance market, while reducing public reliance on government hospitals, which are currently facing congestion and long waiting times. Currently, only around 22 per cent of Malaysians have health insurance, leaving the majority exposed to the risk of high medical expenses. Through the basic product, more individuals will be able to access minimum financial protection at an affordable rate. The MHIT basic plan aims to protect individuals from high healthcare costs while minimising out-of-pocket expenses. It also seeks to simplify the insurance and takaful market by offering a clearer, more straightforward coverage package. Premium pricing and benefit coverage will be determined based on verified treatment cost data. This includes the most common procedures and hospital cost comparisons, to ensure long-term sustainability. To maintain affordability, the MHIT basic plan's network will focus on mid-tier hospitals. Treatments at premium hospitals will be available through optional top-up plans open to competition among insurance and takaful providers. The MHIT basic plan will change the claims process by shifting payments from a fee-for-service system to a diagnosis-related group (DRG) system, which is payment based on diagnosis. The rollout will be conducted in phases to avoid disruption in the market. The DRG approach is expected to help control treatment cost inflation, as private hospitals will be incentivised to operate more efficiently to manage claim volumes by disease category. The new mechanism also supports the 'value-based healthcare' agenda, which is the direction of the national healthcare system. Emphasis is also placed on the role of general practitioners (GPs) as the primary entry point for treatment before patients are referred to private hospitals. This is to strengthen primary care and reduce the tendency of patients to directly seek specialist treatment. Authorities are also considering including coverage for preventive treatments that have been proven to reduce the risk of serious illness. They are also considering allowing coverage for pre-existing conditions under certain conditions such as waiting periods and symptom control. There is also a need to educate the public that the benefits of the basic product must be balanced with their ability to pay premiums. Hence, focus group sessions will be conducted to identify the most relevant coverage priorities. To protect policyholders' interests, insurance and takaful companies will be required to provide a Product Disclosure Sheet (PDS) outlining key benefits, projected long-term premium increases, and alternative options for consumers. In addition, a dedicated complaints mechanism will be established to resolve disputes between private hospitals and insurance operators. Policyholders who struggle with premium increases can seek advice and assistance through the Credit Counselling and Management Agency.
